BPMC logo

Blueprint Medicines (BPMC) Depreciation and amortization

annual D&A:

$16.29M+$4.63M(+39.66%)
December 31, 2024

Summary

  • As of today (June 22, 2025), BPMC annual depreciation & amortization is $16.29 million, with the most recent change of +$4.63 million (+39.66%) on December 31, 2024.
  • During the last 3 years, BPMC annual D&A has risen by +$9.81 million (+151.44%).
  • BPMC annual D&A is now at all-time high.

Performance

BPMC Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBPMCincome statement metrics

quarterly D&A:

$4.46M+$458.00K(+11.45%)
March 31, 2025

Summary

  • As of today (June 22, 2025), BPMC quarterly depreciation & amortization is $4.46 million, with the most recent change of +$458.00 thousand (+11.45%) on March 31, 2025.
  • Over the past year, BPMC quarterly D&A has dropped by -$351.00 thousand (-7.30%).
  • BPMC quarterly D&A is now -36.45% below its all-time high of $7.02 million, reached on December 31, 2022.

Performance

BPMC quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBPMCincome statement metrics

TTM D&A:

$15.94M-$351.00K(-2.15%)
March 31, 2025

Summary

  • As of today (June 22, 2025), BPMC TTM depreciation & amortization is $15.94 million, with the most recent change of -$351.00 thousand (-2.15%) on March 31, 2025.
  • Over the past year, BPMC TTM D&A has increased by +$3.15 million (+24.62%).
  • BPMC TTM D&A is now -7.06% below its all-time high of $17.15 million, reached on September 30, 2023.

Performance

BPMC TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBPMCincome statement metrics

BPMC Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+39.7%-7.3%+24.6%
3 y3 years+151.4%+173.9%+145.3%
5 y5 years+209.8%+183.8%+182.0%

BPMC Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+151.4%-36.5%+203.3%-7.1%+150.0%
5 y5-yearat high+209.8%-36.5%+203.3%-7.1%+182.0%
alltimeall timeat high+3151.7%-36.5%+3227.6%-7.1%>+9999.0%

BPMC Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$4.46M(+11.4%)
$15.94M(-2.2%)
Dec 2024
$16.29M(+39.7%)
$4.00M(+3.6%)
$16.29M(+17.9%)
Sep 2024
-
$3.86M(+6.8%)
$13.82M(+7.7%)
Jun 2024
-
$3.62M(-24.8%)
$12.83M(+0.3%)
Mar 2024
-
$4.81M(+214.2%)
$12.79M(+9.7%)
Dec 2023
$11.66M(-0.6%)
$1.53M(-46.7%)
$11.66M(-32.0%)
Sep 2023
-
$2.87M(-19.7%)
$17.15M(+7.9%)
Jun 2023
-
$3.58M(-2.9%)
$15.90M(+15.3%)
Mar 2023
-
$3.68M(-47.5%)
$13.79M(+17.5%)
Dec 2022
$11.73M(+81.1%)
$7.02M(+332.8%)
$11.73M(+83.9%)
Sep 2022
-
$1.62M(+10.3%)
$6.38M(+0.1%)
Jun 2022
-
$1.47M(-9.7%)
$6.38M(-1.9%)
Mar 2022
-
$1.63M(-2.1%)
$6.50M(+0.3%)
Dec 2021
$6.48M(-1.2%)
$1.66M(+2.9%)
$6.48M(-0.1%)
Sep 2021
-
$1.62M(+1.5%)
$6.49M(-0.5%)
Jun 2021
-
$1.59M(-1.0%)
$6.52M(-1.2%)
Mar 2021
-
$1.61M(-3.8%)
$6.60M(+0.6%)
Dec 2020
$6.56M(+24.7%)
$1.67M(+1.5%)
$6.56M(+1.5%)
Sep 2020
-
$1.65M(-1.2%)
$6.46M(+5.8%)
Jun 2020
-
$1.67M(+6.2%)
$6.11M(+8.0%)
Mar 2020
-
$1.57M(-0.2%)
$5.65M(+7.5%)
Dec 2019
$5.26M
$1.57M(+21.7%)
$5.26M(+8.3%)
Sep 2019
-
$1.29M(+6.5%)
$4.86M(+2.8%)
DateAnnualQuarterlyTTM
Jun 2019
-
$1.21M(+3.1%)
$4.72M(+1.7%)
Mar 2019
-
$1.18M(+0.7%)
$4.64M(+9.4%)
Dec 2018
$4.25M(+169.1%)
$1.17M(+0.6%)
$4.25M(+22.5%)
Sep 2018
-
$1.16M(+2.6%)
$3.47M(+28.4%)
Jun 2018
-
$1.13M(+45.3%)
$2.70M(+37.8%)
Mar 2018
-
$780.00K(+99.5%)
$1.96M(+24.2%)
Dec 2017
$1.58M(-0.3%)
$391.00K(-1.3%)
$1.58M(-0.1%)
Sep 2017
-
$396.00K(+0.8%)
$1.58M(-0.7%)
Jun 2017
-
$393.00K(-1.3%)
$1.59M(-0.2%)
Mar 2017
-
$398.00K(+1.3%)
$1.59M(+0.8%)
Dec 2016
$1.58M(+66.9%)
$393.00K(-3.4%)
$1.58M(+3.9%)
Sep 2016
-
$407.00K(+2.8%)
$1.52M(+15.4%)
Jun 2016
-
$396.00K(+2.6%)
$1.32M(+17.2%)
Mar 2016
-
$386.00K(+15.9%)
$1.13M(+18.7%)
Dec 2015
$948.00K(+52.4%)
$333.00K(+63.2%)
$948.00K(+15.5%)
Sep 2015
-
$204.00K(+1.0%)
$821.00K(+8.0%)
Jun 2015
-
$202.00K(-3.3%)
$760.00K(+9.0%)
Mar 2015
-
$209.00K(+1.5%)
$697.00K(+12.1%)
Dec 2014
$622.00K(+24.2%)
$206.00K(+44.1%)
$622.00K(+49.5%)
Sep 2014
-
$143.00K(+2.9%)
$416.00K(+52.4%)
Jun 2014
-
$139.00K(+3.7%)
$273.00K(+103.7%)
Mar 2014
-
$134.00K
$134.00K
Dec 2013
$501.00K
-
-

FAQ

  • What is Blueprint Medicines annual depreciation & amortization?
  • What is the all time high annual D&A for Blueprint Medicines?
  • What is Blueprint Medicines annual D&A year-on-year change?
  • What is Blueprint Medicines quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Blueprint Medicines?
  • What is Blueprint Medicines quarterly D&A year-on-year change?
  • What is Blueprint Medicines TTM depreciation & amortization?
  • What is the all time high TTM D&A for Blueprint Medicines?
  • What is Blueprint Medicines TTM D&A year-on-year change?

What is Blueprint Medicines annual depreciation & amortization?

The current annual D&A of BPMC is $16.29M

What is the all time high annual D&A for Blueprint Medicines?

Blueprint Medicines all-time high annual depreciation & amortization is $16.29M

What is Blueprint Medicines annual D&A year-on-year change?

Over the past year, BPMC annual depreciation & amortization has changed by +$4.63M (+39.66%)

What is Blueprint Medicines quarterly depreciation & amortization?

The current quarterly D&A of BPMC is $4.46M

What is the all time high quarterly D&A for Blueprint Medicines?

Blueprint Medicines all-time high quarterly depreciation & amortization is $7.02M

What is Blueprint Medicines quarterly D&A year-on-year change?

Over the past year, BPMC quarterly depreciation & amortization has changed by -$351.00K (-7.30%)

What is Blueprint Medicines TTM depreciation & amortization?

The current TTM D&A of BPMC is $15.94M

What is the all time high TTM D&A for Blueprint Medicines?

Blueprint Medicines all-time high TTM depreciation & amortization is $17.15M

What is Blueprint Medicines TTM D&A year-on-year change?

Over the past year, BPMC TTM depreciation & amortization has changed by +$3.15M (+24.62%)
On this page